Revision Skincare C+ Correcting Complex 30%
Revision Skincare C+ Correcting Complex 30%
Combat + Correct With the Power of Plus
C+ Correcting Complex 30%® - Reveal a brilliant glow, a more even skin tone and a more youthful appearance. Infused with our patent-pending MelaPATH® technology that illuminates, refines, and rejuvenates, C+ Correcting Complex 30%® defends and corrects the skin-damaging effects of free radicals generated by Urban Dust and High Energy Visible light (HEV or blue light).
- Helps to support the skin’s natural production of Vitamins C and E
- Delivers the next generation of Vitamin C - correcting existing damage and defending your skin for the future
- Supports the skin’s Microbiome with prebiotic technology
- Non-comedogenic
30mL
Water (Aqua), Tetrahexyldecyl Ascorbate, Pentylene Glycol, Dimethyl Isosorbide, Hydrolyzed Eruca Sativa Leaf, Glycerin, Zea Mays (Corn) Starch, Cetearyl Glucoside, Hydrogenated Lecithin, Acetyl Zingerone, Palmitoyl Glycine, Cyclopentasiloxane, Glyceryl Caprylate, Plantago Lanceolata Leaf Extract, Diglucosyl Gallic Acid, Squalane, Sodium Carboxymethyl Beta-Glucan, Euterpe Oleracea Fruit Extract, Ergothioneine, Punica Granatum Extract, Tocopherol, Ubiquinone, Acrylates/C10-30 Alkyl Acrylate Crosspolymer, Triethanolamine, Tocopheryl Acetate, Leuconostoc/Radish Root Ferment Filtrate, Phenoxyethanol, Disodium EDTA, PPG-12/SMDI Copolymer, Xanthan Gum.
Use morning and evening after cleansing, but before moisturizing. Dispense one pump into palm of hand and apply evenly to the face, avoiding the eye area. Be sure to use a daily anti-aging moisturizer with sunscreen such as Intellishade® (Original, Matte or TruPhysical) or Multi-Protection Broad-Spectrum SPF 50 to further protect skin from environmental stressors.
87% of users reported visibly brighter skin*
94% of users reported an improvement in the evenness of skin tone*
84% of users reported visibly firmer skin*
90% of users reported an improvement in overall skin appearance*
*Based on results of a self-assessment questionnaire given to 31 women, ages 38-60, after 12 weeks of directed use, two times daily. Data on file. Results may vary.